GABAergic interneurons are the targets of
cannabinoid actions in the human hippocampus
by
Katona I, Sperlagh B, Magloczky Z, Santha E,
Kofalvi A, Czirjak S, Mackie K, Vizi ES, Freund TF
Institute of Experimental Medicine,
Hungarian Academy of Sciences,
P.O. Box 67, H-1450,
Budapest, Hungary
Neuroscience 2000 Oct 11; 100(4):797-804
ABSTRACTCannabinoids have been shown to disrupt memory processes in mammals including humans. Although the CB1 neuronal cannabinoid receptor was identified several years ago, neuronal network mechanisms mediating cannabinoid effects are still controversial in animals, and even more obscure in humans. In the present study, the localization of CB1 receptors was investigated at the cellular and subcellular levels in the human hippocampus, using control post mortem and epileptic lobectomy tissue. The latter tissue was also used for [3H]GABA release experiments, testing the predictions of the anatomical data. Detectable expression of CB1 was confined to interneurons, most of which were found to be cholecystokinin-containing basket cells. CB1-positive cell bodies showed immunostaining in their perinuclear cytoplasm, but not in their somadendritic plasmamembrane. CB1-immunoreactive axon terminals densely covered the entire hippocampus, forming symmetrical synapses characteristic of GABAergic boutons. Human temporal lobectomy samples were used in the release experiments, as they were similar to the controls regarding cellular and subcellular distribution of CB1 receptors. We found that the CB1 receptor agonist, WIN 55,212-2, strongly reduced [3H]GABA release, and this effect was fully prevented by the specific CB1 receptor antagonist SR 141716A.This unique expression pattern and the presynaptic modulation of GABA release suggests a conserved role for CB1 receptors in controlling inhibitory networks of the hippocampus that are responsible for the generation and maintenance of fast and slow oscillatory patterns. Therefore, a likely mechanism by which cannabinoids may impair memory and associational processes is an alteration of the fine-tuning of synchronized, rhythmic population events.CB1
CB2
Hemp oil
Cytokines
Swiss hemp
Rimonabant
Hemp seeds
Anandamide
Tolerant mice
Just say know
Cannabis: effects
Forgetful rodents
Endocannabinoids
Stoned as a newt?
Stoned chocaholics?
The nectar of delight
Charas versus bhang
CB1 cannabinoid receptor agonism isn't rewarding01 02 03 04 05 06 07 08 09 10 11 12 13 14 15
Refs
HedWeb
Future Opioids
BLTC Research
Paradise-Engineering
Utopian Pharmacology
The Hedonistic Imperative
When Is It Best To Take Crack Cocaine?
The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family
